JAMA’s Findings on Sinopharm’s Efficacy Will Allow Public Health Officials in the Global South to Sleep Better at Night

The prestigious Journal of the American Medical Association published results on Wednesday of new phase 3 clinical trials of Sinopharm’s COVID-19 vaccine and confirmed that the jab’s efficacy rate is between 72-78%.

More importantly, the trials also confirmed that Sinopharm’s vaccine prevents hospitalization and death in almost all instances, which is critical for developing countries with weak public health systems. So, even if people get infected, they can recover at home without overburdening local hospitals.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

OR

Already a subscriber? Log in Click Here to Learn More
by Eric Olander

Most Read

1
Developing Countries’ Debt Servicing Costs to China Are Significant, but Nowhere Near as Much as Other Creditors
2 Chinese Military Fans Discuss Why Indonesia Bought Rafale Instead of J-10C
3
Chinese Cargo Planes Secretly Ferrying Supplies to Iran, Claim Online Sleuths
4
Indonesia Goes Nuclear, Taps China and Russia for Modular Reactors
5
Indonesia Begins $5.9 Billion Chinese EV Battery Project Despite Environment Fears
6 Trump’s Contradictory Iran Strategy Leaves U.S. Weaker After War’s End, Says Chinese Commentator

You Might Like

Morocco Isn’t Going to Rely Only on China For a COVID-19 Vaccine

With more than 65,000 COVID-19 infections, Morocco is one of Africa’s major hot spots in the ongoing pandemic, so it’s not surprising that the government is moving quickly to position ...

Global Times: Africa and Latin America Will Prefer a Chinese-Made COVID-19 Vaccine

Chinese propaganda outlets are moving to frame the narrative that Chinese-made COVID-19 vaccines are better suited for developing countries compared to those made by U.S. and European organizations.  “African and some Latin American ...

Amid Rising COVID Infection Rates, Kenya Looks to China For Help in Securing Vaccine Supplies

President Uhuru Kenyatta directed the Health Ministry to open talks with China to secure supplies of a future COVID-19 vaccine. Until now, Kenya had planned to depend on the global ...

Alibaba’s Formidable Logistics Operation Teams Up With Ethiopian Airlines to Deliver C19 Vaccines Around the World

China is turning to Alibaba, the massive Chinese e-commerce company, to help with the logistics in the distribution of future COVID-19 vaccines to countries throughout Africa, the Middle East, and Latin America.  Cainiao ...

What is The China-Global South Project?

Independent

The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.

News

A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.

Analysis

Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.

Networking

A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.

More about CGSP